2023 annual financial data
GT Biopharma 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -13,576,000 USD and net income was -7,597,000 USD.
Operating cash flow was -8,852,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,576,000 USD
- Net income
- -7,597,000 USD
- Operating cash flow
- -8,852,000 USD